H2-antihistamines for the treatment of anaphylaxis with and without shock: a systematic review
- 1 February 2014
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 112 (2) , 126-131
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Anaphylaxis in emergency department patients 50 or 65 years or olderAnnals of Allergy, Asthma & Immunology, 2011
- World Allergy Organization anaphylaxis guidelines: SummaryJournal of Allergy and Clinical Immunology, 2011
- World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settingsAnnals of Allergy, Asthma & Immunology, 2010
- H1‐antihistamines for the treatment of anaphylaxis: Cochrane systematic reviewAllergy, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- Emergency department anaphylaxis: A review of 142 patients in a single yearJournal of Allergy and Clinical Immunology, 2001
- Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonistsAnnals of Emergency Medicine, 2000
- Therapeutic efficacy of combined -receptor-antagonists on severe histamine-induced cardiovascular reactions in humansInflammation Research, 1992
- Histamine antagonists in the treatment of acute allergic reactionsAnnals of Emergency Medicine, 1992
- Effects of infused histamine: Correlation of plasma histamine levels and symptomsJournal of Allergy and Clinical Immunology, 1982